News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Serologicals Corporation (SERO) Agrees To Acquire LINCO Research Inc. In A $74.8 Million Deal



3/24/2006 10:58:09 AM

ATLANTA--(BUSINESS WIRE)--March 23, 2006--Serologicals Corporation (NASDAQ: SERO) announced today a definitive agreement to acquire LINCO, a privately owned life sciences company focused on supplying research assays and test kits for the Luminex-based Multiplexing platform and other immunoassays. Based in St. Louis, Missouri, LINCO consists of two companies - LINCO Research Inc. (LRI) and LINCO Diagnostic Services, Inc. (LDS). LRI is a life sciences provider of Multiplex, ELISA and RIA immunoassay products and technologies, while LDS provides bioanalytical contract services supporting research and new pharmaceutical drug development.

Read at BioSpace.com
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES